In March 2006, SkyePharma Plc, an official listed UK pharmaceutical, biotechnology and drug delivery public company faced an EGM battle against a substantial minority of rebel shareholders seeking to take control of the company.
June Paddock and Michael Kashis of Fasken Martineau Stringer Saul advised SkyePharma on this matter preventing the takeover.